Affiliation: University of Southampton
- Health economic evaluation in EnglandJames Raftery
University of Southampton, Southampton, United Kingdom Electronic address
Z Evid Fortbild Qual Gesundhwes 108:367-74. 2014..As a result, the National Health Service in England has denied few technologies on grounds of cost-effectiveness. ..
- Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHDDonna C McCann
Developmental Brain and Behaviour Lab, Psychology, University of Southampton, Southampton SO17 1BJ, UK
Trials 15:142. 2014..This trial will compare the adapted-NFPP with a generic parenting group-based programme, Incredible Years (IY), which has been recommended for children with preschool-type ADHD symptoms...
- Health Technology Assessment in the UKJames Raftery
University of Southampton, Wessex Institute, Southampton, UK
Lancet 382:1278-85. 2013..We identify features that might be of value to other health systems as they confront the challenges of rapid innovation and rising costs. We use examples of recent studies to show the strengths and weaknesses of the programme. ..
- Review of NICE's recommendations, 1999-2005James Raftery
Wessex Institute of Health Research and Development, University of Southampton, Southampton SO16 7PX
BMJ 332:1266-8. 2006
- Possible net harms of breast cancer screening: updated modelling of Forrest reportJames Raftery
Faculty of Medicine, Wessex Institute, University of Southampton, Southampton SO16 7PX, UK
BMJ 343:d7627. 2011..To assess the claim in a Cochrane review that mammographic breast cancer screening could be doing more harm than good by updating the analysis in the Forrest report, which led to screening in the United Kingdom...
- Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approachJames Raftery
School of Medicine, University of Southampton, Southhampton, UK
Int J Technol Assess Health Care 25:1-5. 2009..This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the "payback" framework...
- "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitationLouise Dent
University of Southampton Clinical Trials Unit MP131, University of Southampton, SO16 6YD, UK
Trials 12:83. 2011..Most systematic reviews conclude that another clinical trial is needed. Measures of sufficiency and stability may indicate whether this is true...
- A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancersRuth Davies
School of Management, University of Southampton, UK
Health Care Manag Sci 5:249-58. 2002..A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening...
- Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programmeJames Raftery
Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, UK
Health Technol Assess 19:1-138. 2015..By 2011, the Health Technology Assessment (HTA) programme had published the results of over 100 trials with another 220 in progress. The aim of the project was to develop and pilot 'metadata' on clinical trials funded by the HTA programme...
- Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trialsJames Raftery
University of Southampton, Southampton, UK
Trials 13:140. 2012..Formation of the NIHR in 2006 and increased research spending by the Department of Health may have increased the number of noncommercial trials but no data are available...
- Paying clinicians to join clinical trials: a review of guidelines and interview study of trialistsJames Raftery
Wessex Institute for Health R and D, School of Medicine, University of Southampton, Southampton, UK
Trials 10:15. 2009..The aims were to review relevant guidelines and to collate and analyse views of clinical trialists on the role of payments and other factors that motivated clinicians to join clinical trials...
- An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone supportLucy Yardley
School of Psychology, University of Southampton, Highfield, Southampton, UK
BMC Ear Nose Throat Disord 9:13. 2009..The aim of this trial is to evaluate two new alternative models of delivery that may be more feasible and cost-effective...
- The CHD challenge: comparing four cost-effectiveness modelsDavid Turner
Wessex Institute University of Southampton, Southampton, UK
Value Health 14:53-60. 2011....
- Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trialDavid Turner
Wessex Institute, University of Southampton, Alpha House, Southampton Science Park, Chilworth, Southampton SO16 7NS
BMJ 340:c346. 2010..To assess the cost effectiveness of different management strategies for urinary tract infections...
- Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectivenessJames Raftery
Wessex Institute for Health R and D, Medical School, University of Southampton, Southampton, UK
Br J Ophthalmol 91:1244-6. 2007..Continued unlicensed use of bevacizumab raises ethical, legal and policy questions. Public pressure may be the most potent weapon in persuading Genentech to license bevacizumab for AMD...
- Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysisFujian Song
Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
Med Decis Making 22:S26-37. 2002..The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions...
- 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitationMiren Jones
Department of Primary Care and General Practice, University of Birmingham, Birmingham, UK
Fam Pract 24:343-57. 2007..Cardiac rehabilitation (CR) has been shown to improve prognosis and function following an acute myocardial infarction or revascularization. However, participation in CR programmes is low and adherence is poor...
- Ethnic and sex bias in discretionary awardsJames Raftery
BMJ 326:671-2. 2003
- Counting in-hospital deaths in England: a comparison of hospital computer systems and mortuary registersMohammed Mohammed
Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK
J Health Serv Res Policy 9:100-3. 2004....
- A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Dawn Swancutt
Department of Primary Care and General Practice, The University of Birmingham, UK
BMC Cardiovasc Disord 4:12. 2004..The value of clinical assessment and echocardiography as additional methods of risk stratification for thromboembolic disease in patients with AF were also evaluated...
- Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with needClaire Packer
Department of Public Health and Epidemiology, The University of Birmingham, Edgbaston, UK
Int J Technol Assess Health Care 20:531-6. 2004..To describe the adoption and take up of thrombolytic agents for acute myocardial infarction since 1980 in England and compare use with the estimated ceiling of need...
- Comparing processes of stroke care in high- and low-mortality hospitals in the West Midlands, UKMohammed A Mohammed
Public Health and Epidemiology, Birmingham University, Birmingham, UK
Int J Qual Health Care 17:31-6. 2005....
- Can health technologies be assessed using routine data?Andrew J Stevens
Department of Public Health and Epidemiology, University of Birmingham, UK
Int J Technol Assess Health Care 21:96-103. 2005..The potential of routine data for health technology assessment (HTA) in the United Kingdom was assessed...
- Predicting the impact of new health technologies on average length of stay: development of a prediction frameworkSue Simpson
Dept of Public Health and Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Int J Technol Assess Health Care 21:487-91. 2005..The aim of this study was to develop a framework to predict the impact of new health technologies on average length of hospital stay...
- Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysisSue Jowett
Health Economics Facility, Health Services Management Centre, University of Birmingham, Birmingham, UK
Br J Haematol 134:632-9. 2006..However, PSM may have other benefits in relieving pressure on traditional clinic-based care, and the cost-effectiveness of this model of care for some subgroups of anticoagulation patients needs to be explored further...
- Assessing the economic challenges posed by orphan drugs: a comment on Drummond et alChristopher McCabe
Int J Technol Assess Health Care 23:397-401; author reply 401-4. 2007
- NHS activity. Running out of juiceJames Raftery
Health Services Management Centre, Birmingham University
Health Serv J 112:22-3. 2002..Current measurement indicators do not take account of quality, so improvement to services may show up as decreases in efficiency. Quality improvements should be included in productivity measurement...